Screener
Aclaris Therapeutics ACRS Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Aclaris Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Aclaris Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-092065
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Total current assets | 97,765 | 96,316 |
| Marketable securities | 79,065 | 60,612 |
| Property and equipment, net | 664 | 761 |
| Other assets | 2,199 | 2,771 |
| Total assets | $179,693 | $160,460 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $15,516 | $13,158 |
Item 1. Financial Statements
FAQ
- What is Aclaris Therapeutics's deferred tax assets and other non-current assets?
- Aclaris Therapeutics (ACRS) reported deferred tax assets and other non-current assets of $2.2M in Q2 2026.
- How has Aclaris Therapeutics's deferred tax assets and other non-current assets changed year-over-year?
- Aclaris Therapeutics's deferred tax assets and other non-current assets decreased by 26.5% year-over-year, from $2.99M to $2.2M.
- What is the long-term trend for Aclaris Therapeutics's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Aclaris Therapeutics's deferred tax assets and other non-current assets has grown at a -9.3% compound annual growth rate (CAGR), from $4.51M to $2.77M.
- What does deferred tax assets and other non-current assets mean?
- Combined balance of non-current deferred tax assets and other miscellaneous non-current assets.
Ask your AI about Aclaris Therapeutics's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude